Sun Joon Moon
Overview
Explore the profile of Sun Joon Moon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Hong S, Kim M, Lim Y, Moon S, Kwon H, et al.
Biochem Biophys Res Commun
. 2024 Sep;
735:150620.
PMID: 39265364
Sodium-dependent glucose cotransporter-2 (SGLT2) inhibitors, antidiabetic drugs that reduce blood sugar levels by inhibiting glucose reabsorption in the renal proximal tubules, also ameliorate nonalcoholic fatty liver disease (NAFLD). This study...
2.
Jang H, Moon S, Jung J, Han K, Rhee E, Lee W
Endocrinol Metab (Seoul)
. 2024 Aug;
39(5):813-818.
PMID: 39192772
Prior research has highlighted poor clinical outcomes in coronavirus disease 2019 (COVID-19)-infected patients with diabetes; however, susceptibility to COVID-19 infection in patients with diabetes has not been extensively studied. Participants...
3.
Choe H, Ko Y, Moon S, Ahn C, Ha K, Lee H, et al.
Endocrinol Metab (Seoul)
. 2024 Aug;
39(4):622-631.
PMID: 39086276
Backgruound: Dipeptidyl peptidase-4 (DPP4) inhibitors are frequently prescribed for patients with type 2 diabetes; however, their cost can pose a significant barrier for those with impaired kidney function. This study...
4.
Yoo J, Moon S, Park C, Kim J
J Diabetes Sci Technol
. 2024 Jul;
:19322968241262106.
PMID: 39075889
Background: This study demonstrates the difference between glucose management indicator (GMI) and glycated hemoglobin (HbA) according to sensor mean glucose and HbA status using 2 continuous glucose monitoring (CGM) sensors...
5.
Klonoff D, Gabbay M, Moon S, Wilmot E
J Diabetes Sci Technol
. 2024 May;
:19322968241250357.
PMID: 38695387
Continuous glucose monitoring (CGM) has been shown to improve glycemic control and self-monitoring, as well as to reduce the risk of hypoglycemia. Integrated CGM (iCGM) FDA-cleared systems with published performance...
6.
Kim J, Jin S, Kang E, Kwak S, Yang Y, Yoo J, et al.
Diabetologia
. 2024 Apr;
67(7):1235-1244.
PMID: 38634887
Aims/hypothesis: This study compares the efficacy and safety of a tubeless, on-body automated insulin delivery (AID) system with that of a tubeless, on-body sensor-augmented pump (SAP). Methods: This multicentre, parallel-group,...
7.
Jang H, Moon S, Jung J, Han K, Rhee E, Lee W
Endocrinol Metab (Seoul)
. 2024 Jan;
39(3):479-488.
PMID: 38282452
Backgruound: Inconsistent results have been reported regarding the association between the use of antidiabetic drugs and the clinical outcomes of coronavirus disease 2019 (COVID-19). This study aimed to investigate the...
8.
Hong S, Lee J, Moon S, Kwon H, Park S, Rhee E, et al.
Endocrinol Metab (Seoul)
. 2024 Jan;
39(2):353-363.
PMID: 38254294
Backgruound: Polyunsaturated fatty acids (PUFAs) reportedly have protective effects on pancreatic β-cells; however, the underlying mechanisms are unknown. Methods: To investigate the cellular mechanism of PUFA-induced cell protection, mouse insulinoma...
9.
Lee J, Hong S, Kim M, Moon S, Kwon H, Park S, et al.
Diabetes Metab J
. 2024 Jan;
48(1):83-96.
PMID: 38173373
Backgruound: Glucagon-like peptide-1 receptor agonist (GLP-1RA), which is a therapeutic agent for the treatment of type 2 diabetes mellitus, has a beneficial effect on the cardiovascular system. Methods: To examine...
10.
Lee J, Hong S, Kim M, Lim Y, Moon S, Kwon H, et al.
Endocrinol Metab (Seoul)
. 2024 Jan;
39(1):98-108.
PMID: 38171209
Backgruound: Sodium-dependent glucose cotransporter 2 (SGLT2) mediates glucose reabsorption in the renal proximal tubules, and SGLT2 inhibitors are used as therapeutic agents for treating type 2 diabetes mellitus. This study...